glp-1 drugs and breast cancer use linked to lower incidence GLP-1 Medications and Breast Cancer:
Description
The effect of culinary interventions (cooking classes) on dietary intake and behavioral change: a systematic review and evidence map
Clinical considerations for use of initial combination therapy in type 2 diabetes
Genetic predispositions in GLP-1R and glucose-sensing pathways help explain why some individuals benefit more from allulose and why personalized medication selection matters
The structural modification places lysine 30 of the novel incretin agonist in frame with the corresponding lysine residue in the native GIP sequence
Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes
Eye 38:13741379
